226 related articles for article (PubMed ID: 9763851)
1. [Infection with Mycobacterium genavense in 2 HIV-seropositive patients in Amsterdam].
van Ginneken EE; Koopmans PP
Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1629. PubMed ID: 9763851
[No Abstract] [Full Text] [Related]
2. [Mycobacterium genavense infection in 2 HIV seropositive patients in Amsterdam].
Kuijper EJ; de Witte M; Verhagen DW; Kolk AH; van der Meer JT; Dankert J
Ned Tijdschr Geneeskd; 1998 Apr; 142(17):970-2. PubMed ID: 9623172
[TBL] [Abstract][Full Text] [Related]
3. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
4. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
[TBL] [Abstract][Full Text] [Related]
5. The role of didanosine in the management of HIV-1 infection.
Gazzard BG; Moyle GJ
Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients.
Yerly S; Denereaz N; Mermillod B; Hirschel B; Perrin L
Antivir Ther; 1996 Aug; 1(3):167-71. PubMed ID: 11322250
[TBL] [Abstract][Full Text] [Related]
7. [Mycobacterial infections in AIDS].
Perronne C
Rev Prat; 1995 Mar; 45(6):729-32. PubMed ID: 7754311
[TBL] [Abstract][Full Text] [Related]
8. [Management of patients infected by the human immunodeficiency virus (HIV). Report of an expert group].
Delfraissy JF;
Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):312-40. PubMed ID: 12545131
[No Abstract] [Full Text] [Related]
9. Successful cardiac transplantation in an HIV-1-infected patient with advanced disease.
Calabrese LH; Albrecht M; Young J; McCarthy P; Haug M; Jarcho J; Zackin R
N Engl J Med; 2003 Jun; 348(23):2323-8. PubMed ID: 12788996
[No Abstract] [Full Text] [Related]
10. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
Calista D; Boschini A; Landi G
Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
[TBL] [Abstract][Full Text] [Related]
12. [Zidovudine plus didanosine in HIV infected asymptomatic patients previously treated with zidovudine].
López-Martínez C; Guarner J; Magis-Rodríguez C; Uribe-Zúñiga P; del Río-Chiriboga C
Rev Invest Clin; 1998; 50(4):335-9. PubMed ID: 9830323
[TBL] [Abstract][Full Text] [Related]
13. Opportunistic infections shortly after beginning highly active antiretroviral therapy.
Rodríguez-Rosado R; Soriano V; Dona C; González-Lahoz J
Antivir Ther; 1998; 3(4):229-31. PubMed ID: 10682143
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategies against HIV: status in 1994 and future prospectives].
Internist (Berl); 1994 Jul; 35(7 Suppl):1-24. PubMed ID: 9131074
[No Abstract] [Full Text] [Related]
16. [Antiretroviral therapy 1994 versus 2004. The reality illustrated by typical cases].
Kuhlmann B; Trein A
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():72-3. PubMed ID: 15373057
[No Abstract] [Full Text] [Related]
17. A semiparametric Bayesian approach to the random effects model.
Kleinman KP; Ibrahim JG
Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242
[TBL] [Abstract][Full Text] [Related]
18. Totally implantable venous access device infections in patients with AIDS.
Hellard M; Fuller A; Spelman D; Spicer WJ; Pickles R; Jenney A
AIDS; 1997 Apr; 11(5):697-8. PubMed ID: 9108962
[No Abstract] [Full Text] [Related]
19. Effect of anti retroviral therapy (ART) on CD4 T lymphocyte count and the spectrum of opportunistic infections in HIV/AIDS in Manipur.
Chitra Y; Urgen S; Dayananda I; Brajachand SN
J Commun Dis; 2009 Mar; 41(1):19-24. PubMed ID: 19886171
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
